BUNDESINSTITUT FUR ARZNEIMITTEL UND MEDIZINPRODUKTE - Germany 

Ranking results:

Past rankings:

2020
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
2019
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
2018
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
2016
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2014
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2009
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000

Ranking timeline:

Project Participation Performance(2010-01-01 - 2025-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 11
As coordinator: 2
As participant: 9
Sole participant: 0
Coordinator / Participant Ratio: 0.22*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2023 6.999.425 0 1.495.829 1
2022 0 22.561.532 101.875 1
2020 0 9.715.605 95.250 2
2019 1.986.000 18.994.884 864.031 1 1
2018 0 3.942.861 0 1
2017 0 20.200.000 200.000 1
2016 0 14.936.613 393.125 1
2014 0 2.268.505 48.647 1
2013 0 497.378 2.675 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
AGENCIA ESPANOLA DE MEDICAMENTOS Y PRODUCTOS SANITARIOS4
UNIVERSITY OF HELSINKI4
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V3
INFARMED AUTORIDADE NACIONAL DO MEDICAMENTO E PRODUTOS DA SAUDE IP3
MEDIZINISCHE UNIVERSITAET WIEN3
UPPSALA UNIVERSITET3
AGENTSCHAP COLLEGE TER BEOORDELING VAN GENEESMIDDELEN2
AGES OSTERREICHISCHE AGENTUR FUR GESUNDHEIT UND ERNAHRUNGSSICHERHEIT2
AZIENDA REGIONALE PER L'INNOVAZIONEE GLI ACQUISTI2
CELGENE MANAGEMENT SARL2
CHARITE UNIVERSITAETSMEDIZIN BERLIN2
DEPARTMENT OF HEALTH2
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM2
EUROPEAN GROUP FOR BLOOD AND MARROW TRANSPLANTATION2
EUROPEAN HEMATOLOGY ASSOCIATION2
EUROPEAN RESEARCH INITIATIVE ON CLL EV2
FEDERAL AGENCY FOR MEDICINES AND HEALTH PRODUCTS2
FONDAZIONE ITALIANA SINDROMI MIELODISPLASTICHE ETS2
FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS2
FUNDACION HOSPITAL LA FE2
FUNDACION INSTITUTO DE ESTUDIOS DE CIENCIAS DE LA SALUD DE CASTILLA Y LEON2
GENOME RESEARCH2
GMV SOLUCIONES GLOBALES INTERNET SAU2
GPOH GEMEINNUTZIGE2
GROUPE FRANCOPHONE DES MYELODYSPLASIES2
HEALTH PRODUCTS REGULATORY AUTHORITY2
HL7 INTERNATIONAL FONDATION2
HRVATSKI ZAVOD ZA ZDRAVSTVENO OSIGURANJE2
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE2
INTEGRATING THE HEALTHCARE ENTERPRISEEUROPE AISBL2
KAROLINSKA INSTITUTE2
LAAKEALAN TURVALLISUUSJA KEHITTAMISKESKUS2
LAKEMEDELSVERKET2
LEUKANET EV2
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN2
MASARYKOVA UNIVERZITA2
MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY2
MEDISAPIENS OY2
MENARINI RICERCHE2
MINISTERO DEL LAVORO DELLA SALUTE E DELLE POLITICHE SOCIALI2
MLL MUNCHNER LEUKAMIELABOR2
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE2
NOVARTIS PHARMA2
OSPEDALE PEDIATRICO BAMBINO GESU2
REGIONE LOMBARDIA2
SERVICIO ANDALUZ DE SALUD2
SPMS SERVICOS PARTILHADOS DO MINISTERIO DA SAUDE EPE2
STICHTING NATIONAAL ICT INSTITUUT IN DE ZORG2
STICHTING VUMC2
STIFTUNG ELN FOUNDATION2
SYNAPSE RESEARCH MANAGEMENT PARTNERS SL2
THE LYMPHOMA STUDY ASSOCIATION2
UNIVERSIDAD DE NAVARRA2
UNIVERSITA DEGLI STUDI DI TORINO2
UNIVERSITAET ULM2
UNIVERSITAETSMEDIZIN GOETTINGEN GEORGAUGUSTUNIVERSITAET GOETTINGEN STIFTUNG OEFFENTLICHEN RECHTS2
UNIVERSITY OF BOLOGNA2
UNIVERSITY OF NEWCASTLE UPON TYNE2
UNIVERZA V LJUBLJANI2
VIB VZW2
ABBVIE INC1
ACADEMISCH ZIEKENHUIS LEIDEN1
AGENCE DU NUMERIQUE EN SANTE1
AGENCE NATIONALE DE SECURITE DU MEDICAMENT ET DES PRODUITS DE SANTE1
AGENCIJA ZA LIJEKOVE I MEDICINSKE PROIZVODE1
AGENZIA ITALIANA DEL FARMACO1
AGENZIA PER L'ITALIA DIGITALE1
AMGEN1
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS1
ASTRAZENECA1
AZIENDA OSPEDALIERA UNIVERSITARIA FEDERICO II1
BARTS AND THE LONDON NHS TRUST1
BAYER1
BAYER PHARMA1
BEACON: FOR RARE DISEASES1
BETH ISRAEL DEACONESS MEDICAL CENTER INC NON PROFIT CORPORATION1
BIOLOGIS GENETIC INFORMATION MANAGEMENT1
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG1
BUNDESINSTITUT FUER RISIKOBEWERTUNG1
BUNDESINSTITUT FUR IMPFSTOFFE UND BIOMEDIZINISCHE ARZNEIMITTEL1
BUNDESMINISTERIUM FUER BILDUNG UND FORSCHUNG1
BUNDESMINISTERIUM FUER GESUNDHEIT1
CENTRO DI RIFERIMENTO ONCOLOGICO DI AVIANO1
CHEMOTARGETS SL1
CLINICAL TRIALS CONSULTING & TRAINING LIMITED1
COMITE EUROPEEN DE COORDINATION DES INDUSTRIES RADIOLOGIQUES ELECTROMEDICALES ET D INFORMATIQUE DE SANTE AISBL1
COMMISSARIAT A L'ENERGIE ATOMIQUE1
CSC TIETEEN TIETOTEKNIIKAN KESKUS OY1
DATAWIZARD1
DEUTSCHES ZENTRUM FUER LUFT UND RAUMFAHRT EV1
DEUTSCHES ZENTRUM FUR LUFT UND RAUMFAHRT EV1
DEUTSCHES ZENTRUM FUR NEURODEGENERATIVE ERKRANKUNGEN EV1
DOMPE FARMACEUTICI1
EATRIS ERIC1
EBERHARD KARLS UNIVERSITAET TUEBINGEN1
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE1
ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK1
EHALSOMYNDIGHETEN1
ELGA1
EMPIRICA GESELLSCHAFT FUR KOMMUNIKATIONS UND TECHNOLOGIEFORSCHUNG MBH1

Constancy:

Total number of partners: 276
Partner loyalty:
Frequent Partner: (> 2 projects): 20
Rare Partner: 256
Frequent / Rare Partner Ratio: 0.08

Project overview:

Start dateProjectacronymrolefundingpartners
2023-01-01Development, optimisation and implementation of artificial intelligence methods for real world data analyses in regulatory decision-making and health technology assessment along the product lifecycle Real4Regcoordinator6.999.42510
2022-09-01BUILDING A SUSTAINABLE EUROPEAN INNOVATION PLATFORM TO ENHANCE THE REPURPOSING OF MEDICINES FOR ALL REMEDI4ALLparticipant22.561.53224
2020-10-01HEALTHCARE ALLIANCE FOR RESOURCEFUL MEDICINES OFFENSIVE AGAINST NEOPLASMS IN HEMATOLOGY – PLUS HARMONY PLUSparticipant6.715.62541
2020-09-01X-eHealth: eXchanging electronic Health Records in a commom framework X-eHealthparticipant2.999.98035
2019-12-01Up-scaling the global univocal identification of medicines UNICOMparticipant18.994.88439
2019-01-01Strengthening training of academia in regulatory sciences and supporting regulatory scientific advice (STARS) STARScoordinator1.986.00021
2018-12-01Interdisciplinary training network for advancing Organ-on-a-chip technology in Europe EUROoCparticipant3.942.86121
2017-01-01Healthcare Alliance for Resourceful Medicines Offensive against Neoplasms in HematologY - Sofia ref.: 116026 HARMONYparticipant20.200.00053
2016-01-01Ubiquitous Pharmacogenomics (U-PGx): Making actionable pharmacogenomic data and effective treatment optimization accessible to every European citizen U-PGxparticipant14.936.61317
2014-02-01Innovative methodology for small populations research INSPIREparticipant2.268.5058
2013-09-01Personalized Medicine 2020 and beyond – Preparing Europe for leading the global way (PerMed) PERMEDparticipant497.37818

Alias institution names:

  • BUNDESINSTITUT FUR ARZNEIMITTEL UND MEDIZINPRODUKTE